|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: antenatal Rhogam:whyFrom: Laure (lfolgar@vianwe.com)Tue Mar 28 07:25:09 2006
National Institute for Clinical Excellence. Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. London: National Institute for Clinical Excellence (NICE), 2002:16 Guidance 1.1 It is recommended that routine antenatal anti-D prophylaxis (RAADP) is offered to all non-sensitised pregnant women who are RhD negative. 1.2 The clinician (obstetrician, midwife or general practitioner) responsible for the prenatal care of a non-sensitised RhD-negative woman should discuss with her RAADP and the options available so that the woman can make an informed choice about treatment. This discussion should include the circumstances where RAADP would be neither necessary nor cost effective. Such circumstances might include those where the woman: - has opted to be sterilised after the birth of the baby. - is in a stable relationship with the father of the child, and the father is known or found to be RhD-negative. - is certain that she will not have another child after her current pregnancy. The difference between RAADP (i.e. routine prophylaxis at 28 and 34 weeks) and prophylactic anti-D given because of likely sensitisation should be clearly explained to the woman. 1.3 A woman's use of RAADP at 28 and 34 weeks should not be affected by whether she has already had antenatal anti-D prophylaxis (AADP) for a potentially sensitising event early in pregnancy. A woman's use of postpartum anti-D prophylaxis should similarly not be affected by whether she has had RAADP or AADP as the result of a sensitising event. Beyond this, AADP for a potentially sensitising event and postpartum anti-D prophylaxis are not the remit of this guidance. These matters are covered by the Royal College of Obstetricians and Gynaecologists Green Top 1999 guideline: Use of Anti-D Immunoglobulin for Rh Prophylaxis. 1.4 It is recommended that high-quality information, validated and produced at the national level, is made available to RhD-negative women and the relevant healthcare professionals. L. Folgar OBGYN County Hospital Melilla Spain On 26 Mar 2006 at 0:13, emilio porro wrote: Date sent: Sun, 26 Mar 2006 00:13:31 -0600 Send reply to: ob-gyn-l@obgyn.net From: sanbonav@hotmail.com (emilio porro) To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net> Subject: antenatal Rhogam:why
> Here in Italy we do RHogam protection in Rh negative women only after
> now after vaginal bleeding during pregnancy or abdominal trauma. We do
> every two months during pregnancy indirect Coombs anti_D We dont ask
> from human blood (HIV,EPATITIS AND SO ON) ,needs patient's written Robert J. Carpenter, Jr. MD 6624 Fannin, #2720 Houston, TX 77030 (O) 713-795-4600 (F) 713-795-4422 "Life is difficult" The Road Less Travelled by Scott Peck
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:43:13 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.